Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
LEAPMOTOR (09863) Q1 2026: Sales continue to dominate, with overseas markets becoming the second growth curve.
New Stock News | CICC Intelligent Three Times Filed with Hong Kong Stock Exchange, ranking fourth in the domestic intelligent in-house logistics solution industry.
After oversubscribing by 14855 times, the grey market closed up more than 70%. With no cornerstone investors and no greenshoe option, will Wing Fai Technology (06871) usher in a "soaring moment"?
LEAPMOTOR (09863) Q1 2026: Sales continue to dominate, with overseas markets becoming the second growth curve.
New Stock News | CICC Intelligent Three Times Filed with Hong Kong Stock Exchange, ranking fourth in the domestic intelligent in-house logistics solution industry.
After oversubscribing by 14855 times, the grey market closed up more than 70%. With no cornerstone investors and no greenshoe option, will Wing Fai Technology (06871) usher in a "soaring moment"?
